StockSelector.com
  Research, Select, & Monitor Monday, March 30, 2020 6:34:04 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Akebia Therapeutics$7.96$.9112.91%

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Akebia Therapeutics has an overall rank of 6456 out of 7297 stocks based on 6 positive rankings and 10 negative rankings.

Positive Rankings
90 Day Gain
Akebia Therapeutics rank is 90
10 Day Gain
Akebia Therapeutics rank is 349
Up Ratings Revision
During the past month, the average analyst's rating or recommendation has increased. Among companies that have been upgraded within the past month, Akebia Therapeutics is ranked 374.
Low Put/Call
Akebia Therapeutics has a low Put/Call ratio of 0.25 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Akebia Therapeutics is ranked 677.
Debt-to-Equity
Akebia Therapeutics rank is 1536
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, Akebia Therapeutics is ranked 3760.
Negative Rankings
Negative Revenue Estimate
Akebia Therapeutics rank is 238
Negative ROE
Akebia Therapeutics rank is 359
Negative Net Margin
Akebia Therapeutics rank is 384
Missed Whisper
According to EarningsWhispers.com, Akebia Therapeutics missed the Earnings Whisper number when it last reported earnings. Statistics show that companies that have missed the Earnings Whisper number underperform the market in the short-term.
Negative ROA
Akebia Therapeutics rank is 482
Down EPS Surprise
Akebia Therapeutics missed the consensus earnings estimate when it last reported quarterly earnings.
Negative Cash Growth
Akebia Therapeutics rank is 1293
Price-to-Sales
Akebia Therapeutics rank is 1385
Price-to-Book
Akebia Therapeutics rank is 1426
High vPut/Call
Akebia Therapeutics has a high Put/Call ratio of 0.62 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Akebia Therapeutics is ranked 2008.







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2020 StockSelector.com. All rights reserved.